(Q56897846)

English

Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients (English)

0 references

author

Paolo Antonio Ascierto

series ordinal

2

object named as

Paolo Ascierto

0 references

Nicola Mozzillo

series ordinal

1

object named as

Nicola Mozzillo

0 references

language of work or name

English

0 references

publication date

October 2012

0 references

published in

Clinical & Experimental Metastasis

0 references

volume

29

0 references

page(s)

801-5

0 references

issue

7

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10585-012-9504-2

0 references

cites work

Where are we with adjuvant therapy of stage III and IV melanoma in 2009?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Adjuvant therapy of melanoma with interferon: lessons of the past decade

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Anti-CTL-associated antigen 4: are regulatory T cells a target?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-012-9504-2

retrieved

21 January 2018

Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22752507

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22752507

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10585-012-9504-2

0 references

PubMed ID

22752507

0 references

(Q56897846)

Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)